• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1999 - 2000年期间加替沙星与其他抗生素对美国4009株肺炎链球菌临床分离株的比较活性

Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.

作者信息

White Roger L, Enzweiler Kevin A, Friedrich Lawrence V, Wagner David, Hoban Daryl, Bosso John A

机构信息

Anti-infective Research Laboratory, Medical University of South Carolina, Charleston, USA.

出版信息

Diagn Microbiol Infect Dis. 2002 Jul;43(3):207-17. doi: 10.1016/s0732-8893(02)00391-7.

DOI:10.1016/s0732-8893(02)00391-7
PMID:12106954
Abstract

The susceptibility of 4009 recent clinical isolates of Streptococcus pneumoniae to gatifloxacin, levofloxacin, ciprofloxacin, penicillin, ceftriaxone and azithromycin was determined. Overall rates of susceptibility to these agents were 99.4, 98.7, 71.2, 55.2, 80.9, and 71.3%, respectively. Resistance to all tested agents was associated with penicillin resistance. Of penicillin nonsusceptible isolates, 36% were resistant. Resistance to the fluoroquinolones was unusual and gatifloxacin generally appeared to be four-fold more active than levofloxacin or ciprofloxacin. Multidrug resistant S. pneumoniae accounted for 6.2% of this sample. The lowest rate of susceptibility to non-fluoroquinolone antibiotics was observed in isolates from the South region of the United States, which appeared to be explained by both the proportion of and the inherently higher MICs of certain types of isolates.

摘要

测定了4009株近期临床分离的肺炎链球菌对加替沙星、左氧氟沙星、环丙沙星、青霉素、头孢曲松和阿奇霉素的敏感性。这些药物的总体敏感率分别为99.4%、98.7%、71.2%、55.2%、80.9%和71.3%。对所有测试药物的耐药性均与青霉素耐药性相关。在青霉素不敏感的分离株中,36%具有耐药性。对氟喹诺酮类药物的耐药情况不常见,加替沙星的活性通常似乎比左氧氟沙星或环丙沙星高四倍。多重耐药肺炎链球菌占该样本的6.2%。在美国南部地区分离株中观察到对非氟喹诺酮类抗生素的最低敏感率,这似乎可以通过某些类型分离株的比例及其固有较高的最低抑菌浓度来解释。

相似文献

1
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.1999 - 2000年期间加替沙星与其他抗生素对美国4009株肺炎链球菌临床分离株的比较活性
Diagn Microbiol Infect Dis. 2002 Jul;43(3):207-17. doi: 10.1016/s0732-8893(02)00391-7.
2
In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae.氟喹诺酮类药物(加替沙星、左氧氟沙星和曲伐沙星)及其他七种抗生素对肺炎链球菌的体外活性
Braz J Infect Dis. 2001 Apr;5(2):50-2. doi: 10.1590/s1413-86702001000200001. Epub 2001 Aug 3.
3
Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.通过E试验测定氟喹诺酮类药物对从细菌性角膜炎中分离出的肺炎链球菌的体外比较疗效。
Indian J Pathol Microbiol. 2010 Apr-Jun;53(2):276-80. doi: 10.4103/0377-4929.64337.
4
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.加替沙星与其他喹诺酮类及非喹诺酮类药物相比的抗肺炎球菌活性。
J Antimicrob Chemother. 1999 May;43(5):645-9. doi: 10.1093/jac/43.5.645.
5
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.美国2000 - 2001年和2001 - 2002年TRUST研究中儿童肺炎链球菌、流感嗜血杆菌和卡他莫拉菌临床分离株对左氧氟沙星的敏感性
Antimicrob Agents Chemother. 2003 Jun;47(6):1790-7. doi: 10.1128/AAC.47.6.1790-1797.2003.
6
Emergence of penicillin-resistant Streptococcus pneumoniae ocular infections.耐青霉素肺炎链球菌眼部感染的出现。
Cornea. 1998 Mar;17(2):135-40. doi: 10.1097/00003226-199803000-00003.
7
Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.曲伐沙星、加替沙星、克林沙星、司帕沙星、左氧氟沙星和环丙沙星在体外感染模型中对青霉素耐药肺炎链球菌的活性。
Antimicrob Agents Chemother. 2000 Mar;44(3):598-601. doi: 10.1128/AAC.44.3.598-601.2000.
8
In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.左氧氟沙星及其他三种氟喹诺酮类药物对青霉素敏感和耐药肺炎链球菌的体外抑菌活性
J Antimicrob Chemother. 1999 Jun;43 Suppl C:9-14. doi: 10.1093/jac/43.suppl_3.9.
9
In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.
J Antimicrob Chemother. 1999 Jun;43 Suppl C:15-9. doi: 10.1093/jac/43.suppl_3.15.
10
Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.使用蒙特卡洛模拟对头孢曲松、加替沙星和左氧氟沙星针对肺炎链球菌的药效学分析。
Pharmacotherapy. 2005 Sep;25(9):1161-7. doi: 10.1592/phco.2005.25.9.1161.

引用本文的文献

1
Antimicrobial susceptibility of invasive and lower respiratory tract isolates of Streptococcus pneumoniae, 1998 to 2007.1998 年至 2007 年侵袭性和下呼吸道分离的肺炎链球菌的抗菌药物敏感性。
Can J Infect Dis Med Microbiol. 2009 Winter;20(4):e139-44. doi: 10.1155/2009/413749.
2
Gatifloxacin: a review of its use in the treatment of bacterial infections in the US.加替沙星:美国治疗细菌感染的应用综述
Drugs. 2005;65(5):695-724. doi: 10.2165/00003495-200565050-00007.
3
Pharmacokinetics of gatifloxacin in infants and children.加替沙星在婴幼儿及儿童中的药代动力学
Antimicrob Agents Chemother. 2005 Mar;49(3):1106-12. doi: 10.1128/AAC.49.3.1106-1112.2005.
4
Drug treatment of pneumococcal pneumonia in the elderly.老年人肺炎球菌肺炎的药物治疗。
Drugs Aging. 2004;21(13):851-64. doi: 10.2165/00002512-200421130-00003.
5
Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.左氧氟沙星:美国治疗细菌感染用药综述
Drugs. 2003;63(24):2769-802. doi: 10.2165/00003495-200363240-00008.
6
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.免疫功能正常的成年人社区获得性肺炎管理实践指南的更新
Clin Infect Dis. 2003 Dec 1;37(11):1405-33. doi: 10.1086/380488. Epub 2003 Nov 3.